Cost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong - Concepedia

Concepedia

Publication | Open Access

Cost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong

DOI Full Paper Access

17

Citations

22

References

2020

Year

Thomas S. Y. Chan, Sally Shuk‐Yee Cheng, Wei‐Ting Chen, Danny Hsu, Rene Wing-Yan Chau, Suk Hyun Kang, Adnan Alsumali, Yok‐Lam Kwong

Journal of Medical Economics

Abstract

Letermovir prophylaxis would be cost-effective for preventing CMV infection in adult seropositive allogeneic HSCT recipients in Hong Kong.

References

	Year	Citations

Page 1